RARE — Ultragenyx Pharmaceutical Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 5
- all time
- Members · 12m
- 1
- 3 buys · 0 sells · by trade date
- Latest filing
- 10-12
- 2026-10-12
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 0
- every row filed inside 45 days
- 13F holders
- 255
- all listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29
| Kind | Who | Traded → Filed | Size | Src |
|---|---|---|---|---|
| a disclosed trade in an issuer whose sector falls within a committee the member sat on as of the trade date (versioned mapping; membership dated) — context only: no legal, ethical, or causal conflict is established or implied | Cisneros | Traded → Filed +13d | $1.0K–$15.0K |
1–1 of 1 line · 1 hit · each kind word opens its exact rule · every hit is in signals.v1.json.
COMMITTEE: Context, not an allegation.
Congress · disclosure timeline
By trade date · 24 months · 5 rows ▲ buy, ▼ sell; height = lower bound (log scale); ringed = on Signals. Trade date, not filing date — the filing lag is in the table below.5 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M; 1 ringed mark is a line of the Signals row above, pinned in the table below.
Members active in RARE
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).| Member | Rows | Net disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point. | Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join. |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D–CA-31 | 3 | $3.0K to $45.0K | 2 |
1 member
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2026-10-12 | Gilbert Ray Cisneros, Jr. D–CA-31 On Signals | BUY | Traded 09-29 +13d | $1K–$15K | ||
| 2026-04-07 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 03-03 +35d | $1K–$15K | ||
| 2026-03-09 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 02-18 +19d | $1K–$15K | ||
| 2025-09-12 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 08-08 +35d | $1K–$15K | ||
| 2025-08-14 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 07-15 +30d | $1K–$15K |
13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only
| # | Filer | Value | Securities | Flags | derived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list·§ |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $153M | 1 | derived ·§ EDGAR ↗ | |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | $113M | 1 | derived ·§ EDGAR ↗ | |
| 3 | STATE STREET CORP | $105M | 1 | derived ·§ EDGAR ↗ | |
| 4 | AQR CAPITAL MANAGEMENT LLC | $95.9M | 1 | derived ·§ EDGAR ↗ | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $87.8M | 1 | derived ·§ EDGAR ↗ | |
| 6 | RTW INVESTMENTS, LP | $76.4M | 1 | derived ·§ EDGAR ↗ | |
| 7 | SANDS CAPITAL MANAGEMENT, LLC | $67.3M | 1 | derived ·§ EDGAR ↗ | |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | $55.3M | 1 | derived ·§ EDGAR ↗ | |
| 9 | Bellevue Group AG | $49.9M | 1 | derived ·§ EDGAR ↗ | |
| 10 | Assenagon Asset Management S.A. | $47.3M | 1 | derived ·§ EDGAR ↗ | |
| 11 | TWO SIGMA INVESTMENTS, LP | $46.2M | 1 | derived ·§ EDGAR ↗ | |
| 12 | FRONTIER CAPITAL MANAGEMENT CO LLC | $45.9M | 1 | derived ·§ EDGAR ↗ | |
| 13 | CITADEL ADVISORS LLC | $44.3M | 1 | derived ·§ EDGAR ↗ | |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | $38.8M | 1 | derived ·§ EDGAR ↗ | |
| 15 | MILLENNIUM MANAGEMENT LLC | $37.1M | 1 | derived ·§ EDGAR ↗ | |
| 16 | MORGAN STANLEY | $31.4M | 1 | derived ·§ EDGAR ↗ | |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INC | $30.0M | 1 | derived ·§ EDGAR ↗ | |
| 18 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | $29.9M | 1 | derived ·§ EDGAR ↗ | |
| 19 | D. E. Shaw & Co., Inc. | $26.4M | 1 | derived ·§ EDGAR ↗ | |
| 20 | Rock Springs Capital Management LP | $25.5M | 1 | derived ·§ EDGAR ↗ | |
| 21 | Jones Hill Capital LP | $24.4M | 1 | derived ·§ EDGAR ↗ | |
| 22 | Candriam S.C.A. | $23.0M | 1 | derived ·§ EDGAR ↗ | |
| 23 | BANK OF AMERICA CORP /DE/ | $21.9M | 1 | derived ·§ EDGAR ↗ | |
| 24 | Qube Research & Technologies Ltd | $19.2M | 1 | derived ·§ EDGAR ↗ | |
| 25 | Point72 Asset Management, L.P. | $18.7M | 1 | derived ·§ EDGAR ↗ |
Show all 255 holders
| # | Filer | Value | Securities | Flags | Src·§ |
|---|
All 215 13F filers reporting this share class are listed. Method ↗
Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.
Congress ↔ notable managers · RARE
Congress · last 90 days
- Buyers
- 1 Gilbert Ray Cisneros, Jr. D–CA-31 $1K–$15K
- Sellers
- 0 — —
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers · quarter ended 2026-03-31
- Adding
- 0 — $0 held
- Trimming
- 1 Moore Capital Management $3.3M held
by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · ULTRAGENYX PHARMACEUTICAL IN
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-10-12 | Gilbert Ray Cisneros, Jr. Congress | BUY | $1K–$15K |
| 2026-05-15 | Moore Capital Management 13F | TRIM | −42,868 sh |
2 newest, by filing date · 13F rows are quarter-end snapshots, not trades
Congress vs filers
12 monthsCongress net (rows)3 buy / 0 sell
Congress net ($ bound)$3.0K to $45.0K
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.